Skip to content

Effect of Greeva Basti (Moolak Taila) and Raktamokshan (Wet cupping) In The Management of Manyastambha (Cervical Spondylosis)

A Comparative Clinical Study To Evaluate The Effficacy Of Greeva Basti (Moolak Taila) With Intermittent Raktmoskhan (Wet Cupping) And Only Greeva Basti (Moolak Taila) In The Management Of Manyastambha W.S.R Cervical Spondylosis - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072600
Enrollment
40
Registered
2024-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved DSRRAU Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed and confirmed cases of Manyastambha (Cervical Spondylosis) as per case report on the basis of sign and symptoms Patients between the age group of 18 to 65 years of either sex religion and occupation Patients willing to give written consent

Exclusion criteria

Exclusion criteria: Pregnant and lactating woman Subjects contraindicated for Greeva basti and Raktmokshana Stenosis of spinal canal and myelopathy Patients suffering with other systemic chronic disorders like malignancy and cardiac and renal disease and also diabetic patients Ankylosing spondylitis adhesive capsulitis fracture and dislocation involving shoulder joint Patient having HIV and HEPATITIS infection

Design outcomes

Primary

MeasureTime frame
To see the effect on subjective and objective parametersTimepoint: 30 Days

Secondary

MeasureTime frame
To see any other effects of drug and proceduresTimepoint: 30 Days

Countries

India

Contacts

Public ContactDr Megha Agarwal

Post Graduate Institute of Ayurved

atreyagyan@gmail.com9829798701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026